Literature DB >> 21883173

Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies.

Jehan Suleiman1, Tanja Brenner, Deepak Gill, Christopher Troedson, Adriane J Sinclair, Fabienne Brilot, Angela Vincent, Bethan Lang, Russell C Dale.   

Abstract

Autoantibodies that bind to voltage-gated potassium-channel complex proteins (VGKC-complex antibodies) occur frequently in adults with limbic encephalitis presenting with cognitive impairment and seizures. Recently, VGKC-complex antibodies have been described in a few children with limbic encephalitis, and children with unexplained encephalitis presenting with status epilepticus. We report a case of infantile-onset epileptic spasms and developmental delay compatible with epileptic encephalopathy. Our patient was a female infant, aged 4 months at presentation. She had evidence of immune activation in the central nervous system with elevated cerebrospinal fluid neopterin and mirrored oligoclonal bands, which prompted testing for autoantibodies. VGKC-complex antibodies were elevated (201 pmol/L, normal<100), but extended antibody testing, including leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein 2 (CASPR2), was negative. The patient showed a partial response to steroid treatment, which was started late in the disease course. On review at 13 months of age, her development was consistent with an age of 5 to 6 months. These results suggest that VGKC-complex antibodies might represent a marker of immune therapy responsiveness in a subgroup of patients with infantile epileptic encephalopathy. © The Authors. Developmental Medicine & Child Neurology
© 2011 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883173     DOI: 10.1111/j.1469-8749.2011.04096.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  12 in total

1.  LGI-1-positive limbic encephalitis: a clinicopathological study.

Authors:  Jörg Schultze-Amberger; Debora Pehl; Werner Stenzel
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

Review 2.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 3.  Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.

Authors:  Zhiwei Fang; Yunqi Yang; Xuan Chen; Weiwang Zhang; Yangmei Xie; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

Review 4.  Latest American and European updates on infantile spasms.

Authors:  Andrew L Lux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

Review 5.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

6.  Case Report: Rituximab Improved Epileptic Spasms and EEG Abnormalities in an Infant With West Syndrome and Anti-NMDAR Encephalitis Associated With APECED.

Authors:  Go Kawano; Takaoki Yokochi; Ryuta Nishikomori; Yoriko Watanabe; Keizo Ohbu; Yukitoshi Takahashi; Haruo Shintaku; Toyojiro Matsuishi
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

7.  Major channels involved in neuropsychiatric disorders and therapeutic perspectives.

Authors:  Paola Imbrici; Diana Conte Camerino; Domenico Tricarico
Journal:  Front Genet       Date:  2013-05-07       Impact factor: 4.599

8.  Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens.

Authors:  Yael Hacohen; Sukhvir Wright; Patrick Waters; Shakti Agrawal; Lucinda Carr; Helen Cross; Carlos De Sousa; Catherine Devile; Penny Fallon; Rajat Gupta; Tammy Hedderly; Elaine Hughes; Tim Kerr; Karine Lascelles; Jean-Pierre Lin; Sunny Philip; Keith Pohl; Prab Prabahkar; Martin Smith; Ruth Williams; Antonia Clarke; Cheryl Hemingway; Evangeline Wassmer; Angela Vincent; Ming J Lim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-22       Impact factor: 13.654

9.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

10.  Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy.

Authors:  Melissa L Barker-Haliski; Wolfgang Löscher; H Steve White; Aristea S Galanopoulou
Journal:  Epilepsia       Date:  2017-07       Impact factor: 6.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.